Multiparametric MRI Study of Endogenous Analgesia and Prediction the Efficacy of Migraine Pharmacological Prevention
NACompletedINTERVENTIONAL
Enrollment
179
Participants
Timeline
Start Date
November 16, 2011
Primary Completion Date
November 6, 2017
Study Completion Date
November 6, 2017
Conditions
Migraine
Interventions
DRUG
Doluxetine
30 mg/d
DRUG
Placebo
suger pill 30mg/d
Trial Locations (1)
Unknown
Rambam health care campus, Haifa
All Listed Sponsors
lead
d_yarnitsky
OTHER
NCT01470352 - Multiparametric MRI Study of Endogenous Analgesia and Prediction the Efficacy of Migraine Pharmacological Prevention | Biotech Hunter | Biotech Hunter